Skip to main content
. 2019 Feb 8;14(2):e0211865. doi: 10.1371/journal.pone.0211865

Fig 3. APRIL/BLyS blockade depleted IgM IgG secreting cells compared to non-sensitized sensitized untreated groups.

Fig 3

Each graph shows number of spots per 62,500 lymphocytes. Spots represent antibody secreting cells. (A) IgM secreting cells. (B) IgG secreting cells. Together, decreased plasma cell antibody secreting cell populations add further support to the use of APRIL/BLyS blockade as a therapy to target potentially reduce antibody production.